PRFX PainReform Corp: Long-Term Debt to Capital Coefficient

PainReform Ltd. (PRFX) develops innovative solutions for postoperative relief, helping patients recover without the use of opioids. The company leverages an extensive network of international warehouses, ensuring seamless supplies and high profitability. This chart reflects the current market value on GURU.Markets at 0.00, while the biotech firm optimizes expenses by outsourcing final-stage drug testing to contract research organizations.

This ratio determines the proportion of long-term liabilities relative to equity, measuring the company's degree of financial leverage. An increase in this metric indicates a rising debt load to finance future periods. By analyzing the long-term debt-to-equity chart, an investor assesses the stability of the balance sheet structure. For PainReform Ltd. (PRFX), this is critical, as manufacturing outsourcing requires stable resources. High debt may limit flexibility when switching vendors.